Radioactive 'Seeker' drug tested to attack prostate cancer before surgery
NCT ID NCT06066437
Summary
This study is testing a new radioactive drug designed to find and deliver radiation directly to prostate cancer cells. It is being given to a small group of men with high-risk prostate cancer before they have surgery to remove the prostate. The main goals are to see if the drug dose is safe and to learn if it can shrink or control the tumor when used alone or with standard hormone therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.